UBS Group’s AfterNext HealthTech Acquisition Corp AFTR Stock Holding History
Bought
Maintained
Sold
Other funds holding AFTR
AC
FTCM
GC
UOC
GCL
WCMNY
MCM
FTCM
UBS Group's AFTR Position: Q2 2023 in Review
UBS Group sold out of AfterNext HealthTech Acquisition Corp (AFTR) in Q2 2023, closing a stake of 291 shares — an estimated $2.97K sold.
UBS Group first reported a position in AFTR in Q4 2021 and held it in 3 quarters. The position peaked at $48K in Q1 2022. 47 funds tracked by Wall St. Rank hold AFTR as of Q2 2023.
- UBS Group reported no remaining AfterNext HealthTech Acquisition Corp position as of Q2 2023 after selling out during the quarter.
- UBS Group sold 291 AfterNext HealthTech Acquisition Corp shares in Q2 2023, an estimated $2.97K.
- UBS Group first reported a position in AfterNext HealthTech Acquisition Corp in Q4 2021 and held it in 3 quarters.
- UBS Group's AfterNext HealthTech Acquisition Corp position peaked at $48K in Q1 2022.
- 47 funds tracked by Wall St. Rank held AfterNext HealthTech Acquisition Corp as of Q2 2023.
Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.